SEC filings and other documents

Directors elected, compensation and auditor ratified, no stockholder questions raised.

Solid Q1 performance, strategic investments, and disciplined capital allocation drive growth.

Disciplined pricing and AI investments drove strong Q1 earnings and improved retention outlook.

Disciplined execution drove strong cash flow and margin stability amid persistent cost pressures.

Sharpened SMB focus, strong retention, and AI-driven growth position the business for expansion.

Disciplined pricing and cost control offset lower volumes, driving margins to guidance highs.

Q2 delivered stable results, reaffirmed 2025 guidance, and showed improving customer and broker trends.

Q1 revenue up 1% with strong retention; 2025 guidance affirmed amid ongoing repricing and innovation.

Transition year with strategic refocus, modest growth, and clear path to higher value creation.

Strong HR demand, longer sales cycles, and healthcare cost pressures shape outlook.

Technology, tailored benefits, and disciplined pricing drive growth and retention in the PEO market.

Targeted growth, tech investment, and disciplined capital policy drive expansion in the PEO market.

Focused investments in data, risk, and technology drive growth amid strong retention and market opportunity.

Healthcare cost inflation pressured margins, but record retention and disciplined pricing supported results.